MCID: URT007
MIFTS: 11

Ureter Inverted Papilloma malady

Categories: Cancer diseases

Aliases & Classifications for Ureter Inverted Papilloma

Aliases & Descriptions for Ureter Inverted Papilloma:

Name: Ureter Inverted Papilloma 12 14 69
Ureteral Inverted Papilloma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6935
NCIt 47 C6174
UMLS 69 C1336874

Summaries for Ureter Inverted Papilloma

MalaCards based summary : Ureter Inverted Papilloma, also known as ureteral inverted papilloma, is related to inverted papilloma and papilloma. An important gene associated with Ureter Inverted Papilloma is GP5 (Glycoprotein V Platelet). The drugs Fentanyl and Liver Extracts have been mentioned in the context of this disorder.

Related Diseases for Ureter Inverted Papilloma

Diseases related to Ureter Inverted Papilloma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 inverted papilloma 10.1
2 papilloma 9.9

Symptoms & Phenotypes for Ureter Inverted Papilloma

Drugs & Therapeutics for Ureter Inverted Papilloma

Drugs for Ureter Inverted Papilloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 Liver Extracts Phase 3,Phase 2,Phase 1
3 Adjuvants, Anesthesia Phase 3
4 Analgesics Phase 3
5 Analgesics, Opioid Phase 3
6 Anesthetics Phase 3
7 Anesthetics, General Phase 3
8 Anesthetics, Intravenous Phase 3
9 Central Nervous System Depressants Phase 3
10 Narcotics Phase 3
11 pancreatic polypeptide Phase 3
12 Peripheral Nervous System Agents Phase 3
13 Cola Nutraceutical Phase 3,Phase 2,Phase 1
14
Indinavir Approved Phase 2 150378-17-9 5362440
15
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
16 Anti-HIV Agents Phase 2
17 Anti-Infective Agents Phase 2,Phase 1
18 Anti-Retroviral Agents Phase 2
19 Antiviral Agents Phase 2
20 Cytochrome P-450 CYP3A Inhibitors Phase 2
21 Cytochrome P-450 Enzyme Inhibitors Phase 2
22 HIV Protease Inhibitors Phase 2
23
protease inhibitors Phase 2
24
Docetaxel Approved May 1996, Investigational Phase 1 114977-28-5 148124 9877265
25
Entinostat Phase 1
26 Histone Deacetylase Inhibitors Phase 1
27 Angiogenesis Inhibitors Phase 1
28 Angiogenesis Modulating Agents Phase 1
29 Anti-Bacterial Agents Phase 1
30 Antimitotic Agents Phase 1
31 Immunosuppressive Agents Phase 1

Interventional clinical trials:


id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
3 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1
4 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1

Search NIH Clinical Center for Ureter Inverted Papilloma

Genetic Tests for Ureter Inverted Papilloma

Anatomical Context for Ureter Inverted Papilloma

Publications for Ureter Inverted Papilloma

Variations for Ureter Inverted Papilloma

Expression for Ureter Inverted Papilloma

Search GEO for disease gene expression data for Ureter Inverted Papilloma.

Pathways for Ureter Inverted Papilloma

GO Terms for Ureter Inverted Papilloma

Sources for Ureter Inverted Papilloma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....